Soluble Fibrin Monomer, Plasma
Use
This test assists in the diagnosis of arterial or venous prethrombotic states in various pathological and clinical situations including disseminated intravascular coagulation/intravascular coagulation and fibrinolysis and postoperative monitoring of surgeries with a high risk of thromboses.
Special Instructions
Not provided.
Limitations
A normal soluble fibrin monomer complex does not exclude the presence of thrombosis or early disseminated intravascular coagulation (DIC)/intravascular coagulation and fibrinolysis (ICF). Results from lipemic specimens should be interpreted with caution as lipemia can interfere with this assay, causing an underestimation of the soluble fibrin monomer complex level.
New York Approved
Methodology
Immunoassay (Latex Immunoassay)
Biomarkers
Soluble Fibrin Monomer
Analyte
LOINC Codes
- 93748-2 - Fibrin Monomer PPP IA-mCnc
- 93748-2 - Fibrin Monomer PPP IA-mCnc
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
Not provided
Minimum Volume
Not provided
Container
Special Container
Causes for Rejection
Gross hemolysis, gross lipemia, gross icterus
Stability Requirements
| Temperature | Period |
|---|---|
| Frozen | 14 days |